Recent OTLK News
- Outlook Therapeutics® to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference • GlobeNewswire Inc. • 09/21/2023 12:05:00 PM
- Outlook Therapeutics® to Present at the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 09/05/2023 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 10:21:01 AM
- Outlook Therapeutics® Provides Regulatory Update on FDA Review of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD • GlobeNewswire Inc. • 08/30/2023 10:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/28/2023 04:15:11 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/25/2023 08:31:39 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/14/2023 09:19:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:15:30 PM
- Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2023 and Reiterates Key Anticipated Near-Term Milestones • GlobeNewswire Inc. • 08/14/2023 12:05:00 PM
- Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2023 • GlobeNewswire Inc. • 08/01/2023 12:45:00 PM
- Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2023 and Provides Corporate Update • GlobeNewswire Inc. • 05/15/2023 12:05:00 PM
- Outlook Therapeutics® to Present at the H.C. Wainwright BioConnect Investor Conference • GlobeNewswire Inc. • 04/27/2023 12:05:00 PM
- Outlook Therapeutics® Confirms It Has No Exposure to Silicon Valley Bank • GlobeNewswire Inc. • 03/13/2023 11:00:00 AM
- Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2023 and Provides Corporate Update • GlobeNewswire Inc. • 02/14/2023 01:05:00 PM
- Outlook Therapeutics® to Present at the SVB Securities Global Biopharma Conference • GlobeNewswire Inc. • 02/07/2023 01:05:00 PM
- Outlook Therapeutics® Strengthens Medical Affairs and Commercial Expertise with Appointments of Surendra Sharma, MD, Senior Vice President of Medical Affairs and Glen Olsheim, Executive Director of Commercial Excellence • GlobeNewswire Inc. • 01/19/2023 01:05:00 PM
- Outlook Therapeutics® to Present at the Virtual Investor 2023 Companies to Watch Event • GlobeNewswire Inc. • 01/09/2023 01:05:00 PM
- Outlook Therapeutics® Reports Financial Results for Fiscal Year 2022 and Provides Corporate Update • GlobeNewswire Inc. • 12/29/2022 02:05:00 PM
- Outlook Therapeutics® Enters Definitive Agreement for $31.8 Million Unsecured Convertible Promissory Note • GlobeNewswire Inc. • 12/23/2022 02:00:00 PM
- Outlook Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 12/23/2022 11:00:00 AM
- Outlook Therapeutics® Announces Validation of Marketing Authorization Application by the European Medicines Agency for ONS-5010 as a Treatment for Wet AMD • GlobeNewswire Inc. • 12/22/2022 01:05:00 PM
- Outlook Therapeutics® to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference • GlobeNewswire Inc. • 12/01/2022 01:05:00 PM
- Outlook Therapeutics® to Present at the BTIG Ophthalmology Day • GlobeNewswire Inc. • 11/22/2022 01:05:00 PM
- Wall Street Analysts Are Bullish on Top Healthcare Picks • TipRanks • 11/02/2022 05:21:36 AM
- Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD • GlobeNewswire Inc. • 10/28/2022 12:05:00 PM
FEATURED 1606 Corp. Partners with Cool Blue To Launch ChatCBD, a New AI Customer Experience • Sep 26, 2023 8:37 AM
Branded Legacy Inc. Invests Heavily in Innovation and Growth with $540,000 Expansion • BLEG • Sep 26, 2023 10:37 AM
Avant Technologies Reshaping Future of Supercomputing and AI with Disruptive Private Cloud Infrastructure • AVAI • Sep 26, 2023 8:45 AM
Image Protect Announces Debt Forgiveness in Excess of $1,400,000 Clearing the Path for Pending New Business Development • IMTL • Sep 26, 2023 8:16 AM
CGrowth Capital Inc. Nears Key Milestone in Lithium Mining Expansion • CGRA • Sep 26, 2023 8:08 AM
Green Egg to launch $150 million bond offer for quicklime products production kiln plant Sep 22, 2023 12:11 PM